About Nikolay Savchuk
Form D filings for Brenig Therapeutics in 2024 list Nikolay Savchuk as chief executive officer and director.
Nikolay Savchuk first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Nikolay Savchuk in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nikolay Savchuk works with at each company, as listed on that company's latest Form D.
Brenig Therapeutics, Inc. · Form D, Jul 30, 2024
KG
Keno Gutierrez
Director
ID
Iain Dukes
Executive officer and director
EM
Edward Mathers
Director
MC
Michele Cucullu
Director